Our findings highlight BAP31 as a master coordinator of dopaminergic circuit integrity and a potential therapeutic target to enhance mitochondrial resilience in neurodegenerative disorders, offering new strategies to counteract proteostasis failure in PD and related proteinopathies. This evidence concerns the gene BCAP31 and proteostasis deficiencies.